These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6634907)

  • 1. Action of angiotensin on vascular and intestinal smooth muscle and its antagonism by saralasin.
    Coruzzi G; Poli E; Adami M; Bertaccini G; Starcich B
    Pharmacol Res Commun; 1983 Sep; 15(8):719-34. PubMed ID: 6634907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potent noncompetitive angiotensin II antagonist induces only competitive inhibition of angiotensin III responses.
    Trachte GJ; Peach MJ
    J Cardiovasc Pharmacol; 1983; 5(6):1025-33. PubMed ID: 6196550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding characteristics and vascular effects of various angiotensin II antagonists.
    Criscione L; Thomann H; Whitebread S; de Gasparo M; Bühlmayer P; Herold P; Ostermayer F; Kamber B
    J Cardiovasc Pharmacol; 1990; 16 Suppl 4():S56-9. PubMed ID: 1705629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contractile effects by intracellular angiotensin II via receptors with a distinct pharmacological profile in rat aorta.
    Brailoiu E; Filipeanu CM; Tica A; Toma CP; de Zeeuw D; Nelemans SA
    Br J Pharmacol; 1999 Mar; 126(5):1133-8. PubMed ID: 10205000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin stimulates Ca2(+)-dependent action potentials in cultured smooth muscle cells.
    Johns DW; Sperelakis N
    Eur J Pharmacol; 1990 Oct; 187(2):183-91. PubMed ID: 2272359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings.
    Criscione L; Thomann H; Whitebread S; de Gasparo M; Kamber B
    Biochem Biophys Res Commun; 1990 Jun; 169(2):636-42. PubMed ID: 2357223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Competative antagonism of 8-ala-angiotensin II to angiotensins I and II on isolated rabbit aorta and rat colon.
    Turker RK; Yamamoto MY; Khairallah PA; Bumpus FM
    Eur J Pharmacol; 1971; 15(3):285-91. PubMed ID: 4334171
    [No Abstract]   [Full Text] [Related]  

  • 8. The inhibitory effect of KT3-671, a nonpeptide angiotensin-receptor antagonist, on rabbit and rat isolate vascular smooth muscles: a possible involvement of K(ATP) channels.
    Satake N; Imanishi M; Keto Y; Ishikawa M; Yamada H; Shibata S; Tomiyama A
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):457-67. PubMed ID: 10710133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonpeptide angiotensin II receptor antagonists. III. Structure-function studies.
    Chiu AT; Duncia JV; McCall DE; Wong PC; Price WA; Thoolen MJ; Carini DJ; Johnson AL; Timmermans PB
    J Pharmacol Exp Ther; 1989 Sep; 250(3):867-74. PubMed ID: 2778716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and pharmacology of a noncompetitive antagonist of angiotensin-induced contractions of vascular smooth muscle. [Sarcosyl]1-[cysteinyl (s-methyl)]8-angiotensin II.
    Freer RJ; Sutherland JC; Day AR
    Circ Res; 1980 May; 46(5):720-5. PubMed ID: 7363420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between developmental changes in angiotensin II-induced contractions and stimulation of phosphatidylinositol labeling of rat aorta.
    Schoepp DD; Rutledge CO
    J Pharmacol Exp Ther; 1984 Jun; 229(3):880-6. PubMed ID: 6374101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonist effect of losartan on angiotensin II induced contraction in five isolated smooth muscle assays.
    Liu YJ
    Eur J Pharmacol; 1993 Aug; 240(2-3):147-54. PubMed ID: 8243534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods for analyzing and interpreting cooperativity in dose-response curves--I. Antagonist effects on angiotensin receptors in smooth muscle.
    Moore GJ; Scanlon MN
    Gen Pharmacol; 1989; 20(2):193-8. PubMed ID: 2714616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of Ca++ channel blockers and saralasin on angiotensin II induced contraction in rabbit aortic strip.
    Kheterpal K; Lall SB; Rajdev S; Gupta YK
    Indian J Physiol Pharmacol; 1986; 30(2):166-70. PubMed ID: 3818044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An angiotensin II antagonist with strongly prolonged action.
    Holck M; Bossé R; Fischli W; Gerold H; Escher E
    Biochem Biophys Res Commun; 1989 May; 160(3):1350-6. PubMed ID: 2730646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II contributes to cerebral vasodilatation during hypoxia in the rabbit.
    Maktabi MA; Todd MM; Stachovic G
    Stroke; 1995 Oct; 26(10):1871-6. PubMed ID: 7570741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of neurotransmission by angiotensin I and II in rabbit isolated ear artery.
    Rónai AZ
    Eur J Pharmacol; 1990 Apr; 179(3):281-6. PubMed ID: 2163854
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of competitive antagonists on phasic and tonic components of vascular smooth muscle contraction.
    Watkins RW; Davidson IW
    Arch Int Pharmacodyn Ther; 1980 Apr; 244(2):200-10. PubMed ID: 7406582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nonpeptide angiotensin II receptor antagonist recognizes inter-species differences in angiotensin AT1 receptors.
    Kawano K; Fujishima K; Nagura J; Yasuda S; Shinki ; Hachisu M; Konno F
    Eur J Pharmacol; 1998 Sep; 357(1):33-9. PubMed ID: 9788771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effects of angiotensin and adenosine in the renal microvasculature.
    Weihprecht H; Lorenz JN; Briggs JP; Schnermann J
    Am J Physiol; 1994 Feb; 266(2 Pt 2):F227-39. PubMed ID: 8141324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.